Mylan Pharmaceuticals Inc. et al. vs. Novo Nordisk A/S
Explore the PTAB proceeding IPR2023-00722 filed by Mylan Pharmaceuticals Inc. et al. on 2023-03-16. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2023-00722
Filing Date
2023-03-16
Accorded Filing Date
2023-03-16
Institution Decision Date
2023-10-02
Last Modified Date
2023-12-22
Proceeding Type
IPR
Termination Date
2023-10-02
Trial Status
Institution Denied
Parties & Counsel
Petitioner
Mylan Pharmaceuticals Inc. et al.
Represented By
White, Brandonet alPatent Owner / Respondent
Novo Nordisk A/S
Represented By
Baughman, Jonet alTribunal & Venue
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Patent Information
Respondent Application Number
13412283
Respondent Patent Number
8536122
External Links
Respondent Inventor
Jesper Lau et al
Respondent Tech Center
TC 1600 - Biotechnology & Organic Chemistry
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Firm
/ Entity Name
NOVO NORDISK INC. - INTELLECTUAL PROPERTY DEPARTMENT
Customer
Number
23650
Address
800 Scudders Mill Road, Plainsboro, NJ, 08536, UNITED STATES
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 56129 | Wesley Nicolas | 609-786-5418 |
| 62124 | Leon Lum | 609-786-4172 |
| 63996 | Elizabeth Dingess-Hammond | 317-433-3689 |
| 64519 | Jianjie Hu | 609-786-4129 |
| 74995 | Kathryn Jones | 804-426-7196 |
Proceeding Documents
134
11
Notice: refund approved NOTICE
2023-12-22
FILING PARTY: BOARD
10
Petitioner's Request for Refund of Post-Institution Fees OTHER
2023-12-14
FILING PARTY: PETITIONER
9
Denying Institution of Inter Partes Review 35 U.S.C. § 314 DECISION
2023-10-02
FILING PARTY: BOARD
3003
Exhibit 3003 Exhibit
2023-10-02
FILING PARTY: BOARD
3002
Exhibit 3002 Exhibit
2023-10-02
FILING PARTY: BOARD